Alzheimer’s Disease, Gene Therapy, & the Science of Brain Health with Dr. Mayur S. Parmar
What does the future of Alzheimer's disease research look like, and how can we improve both the quantity and quality of life for individuals living with neurodegenerative diseases?
In this episode of Essence and Essentials, I sit down with Dr. Mayur S. Parmar, Associate Professor of Pharmacology at Nova Southeastern University's Dr. Kiran C. Patel College of Osteopathic Medicine. With a PhD in Pharmacology and Toxicology and over 80 peer-reviewed publications, Dr. Parmar shares his journey in neuroscience research and his work exploring Alzheimer's and Parkinson's disease.
We dive into the science behind Alzheimer's disease, including APOE genetics, amyloid-beta and tau pathology, and the emerging potential of APOE2 gene therapy using adeno-associated viral (AAV) vectors. We also discuss one of Dr. Parmar’s 2025 papers on a natural polyphenol, resveratrol, titled “ Resveratrol's Multifaceted Potential in Alzheimer's Disease: Insights from Preclinical and Clinical Evidence.” (Patel et al., 2025).
Beyond the laboratory, we explore the future of Alzheimer's therapeutics, the importance of evidence-based medicine, and how simple everyday lifestyle choices such as movement may help preserve brain health and reduce the risk of cognitive decline, referencing the Alzheimer’s Association U.S. POINTER Study (Alzheimer's Association, n.d.).
To close, Dr. Parmar shares a personal perspective on finding purpose in research, giving back through community involvement, mentoring future physicians, and making time for family, friendships, and life outside of academia.
In this episode, we discuss:
- The science of Alzheimer's and neurodegenerative disease
- APOE2, APOE3, and APOE4 genetic variants and their relationship to Alzheimer's risk
- AAV-mediated APOE2 gene therapy and emerging clinical research
- Amyloid-beta, tau pathology, and neuroinflammation
- Resveratrol and the distinction between preclinical research and clinical evidence
- Emerging Alzheimer's therapeutics and combination treatment approaches
- Lifestyle interventions for brain health
Tune in for a conversation at the intersection of neuroscience, pharmacology, lifestyle, and human connection.
References
Alzheimer's Association. (n.d.). U.S. POINTER study. https://www.alz.org/us-pointer
Patel, S., Thornton, A., & Parmar, M. S. (2025). Resveratrol's multifaceted potential in Alzheimer's disease: Insights from preclinical and clinical evidence. Molecular Neurobiology, 62(12), 16229–16260. https://doi.org/10.1007/s12035-025-05234-4
Stay tuned with Jasmine Looi with...
“Essence and Essentials” on all podcasting platforms!
Instagram and TikTok: @essenceandessentials_
Youtube: @essenceandessentials